Bausch + Lomb Corp (BLCO) - Total Assets
Based on the latest financial reports, Bausch + Lomb Corp (BLCO) holds total assets worth CA$13.83 Billion CAD (≈ $10.01 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Bausch + Lomb Corp (BLCO) shareholders funds for net asset value and shareholders' equity analysis.
Bausch + Lomb Corp - Total Assets Trend (2019–2024)
This chart illustrates how Bausch + Lomb Corp's total assets have evolved over time, based on quarterly financial data.
Bausch + Lomb Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Bausch + Lomb Corp's total assets of CA$13.83 Billion consist of 20.7% current assets and 79.3% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 2.3% |
| Accounts Receivable | CA$1.03 Billion | 7.6% |
| Inventory | CA$1.04 Billion | 7.7% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$3.49 Billion | 25.9% |
| Goodwill | CA$4.52 Billion | 33.6% |
Asset Composition Trend (2019–2024)
This chart illustrates how Bausch + Lomb Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Bausch + Lomb Corp (BLCO) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bausch + Lomb Corp's current assets represent 20.7% of total assets in 2024, an increase from 14.8% in 2019.
- Cash Position: Cash and equivalents constituted 2.3% of total assets in 2024, up from 1.7% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 58.0% of total assets, a decrease from 63.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 33.6% of total assets.
Bausch + Lomb Corp Competitors by Total Assets
Key competitors of Bausch + Lomb Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Alcon AG
SW:ALC
|
Switzerland | CHF31.53 Billion |
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN
|
USA | $32.49 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
Bausch + Lomb Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.51 | 1.57 | 1.82 |
| Quick Ratio | 0.98 | 0.95 | 1.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$959.00 Million | CA$1.03 Billion | CA$745.00 Million |
Bausch + Lomb Corp - Advanced Valuation Insights
This section examines the relationship between Bausch + Lomb Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.91 |
| Latest Market Cap to Assets Ratio | 0.42 |
| Asset Growth Rate (YoY) | 0.2% |
| Total Assets | CA$13.47 Billion |
| Market Capitalization | $5.65 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Bausch + Lomb Corp's assets below their book value (0.42x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Bausch + Lomb Corp's assets grew by 0.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Bausch + Lomb Corp (2019–2024)
The table below shows the annual total assets of Bausch + Lomb Corp from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CA$13.47 Billion ≈ $9.74 Billion |
+0.20% |
| 2023-12-31 | CA$13.44 Billion ≈ $9.72 Billion |
+20.62% |
| 2022-12-31 | CA$11.14 Billion ≈ $8.06 Billion |
+2.97% |
| 2021-12-31 | CA$10.82 Billion ≈ $7.83 Billion |
-3.93% |
| 2020-12-31 | CA$11.27 Billion ≈ $8.15 Billion |
-1.76% |
| 2019-12-31 | CA$11.47 Billion ≈ $8.30 Billion |
-- |
About Bausch + Lomb Corp
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily d… Read more